The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Occlusion Devices Market During The Forecast Period 2026–2030?
The occlusion devices market size has shown robust expansion in recent years. It is anticipated to increase from $4.2 billion in 2025 to $4.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.6%. This historical growth can be linked to several factors including a rise in cardiovascular diseases, continuous advancements in interventional radiology, the global growth of the aging population, the expansion of hospital infrastructure, and the increasing clinical adoption of embolization techniques.
The market for occlusion devices is projected to experience substantial expansion over the upcoming years. It is forecast to expand to $6.54 billion in 2030, with a compound annual growth rate (CAGR) of 9.2%. This projected growth is largely driven by an increase in neurological disorders, the escalating number of minimally invasive surgical procedures, continuous innovation in device technology, the proliferation of ambulatory care centers, and advantageous reimbursement policies. Key trends anticipated during this period encompass a move towards less invasive procedures, the growing adoption of catheter-based therapies, a heightened preference for embolization techniques, an increase in neurovascular intervention developments, and the need for highly precise occlusion devices.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20584&type=smp
What Drivers Are Expected To Influence The Occlusion Devices Market During The Forecast Period?
The escalating demand for minimally invasive techniques is anticipated to propel the growth of the occlusion devices market in the coming years. Minimally invasive surgeries are defined as surgical methods that employ small incisions or natural body openings to access and treat internal structures, organs, or tissues, aiming to minimize trauma to the patient’s body. These techniques offer medical, financial, and aesthetic benefits that appeal to both patients and healthcare providers, thereby driving their increasing demand across various medical disciplines. Occlusion devices are medical tools utilized in minimally invasive procedures to block or close off blood vessels, ducts, or other pathways within the body. These devices are often employed in fields such as interventional cardiology, radiology, or others to address conditions like aneurysms, abnormal blood flow, or congenital heart defects. For instance, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS) reported that in 2023, the total number of aesthetic procedures approached 35 million, with combined surgical and non-surgical procedures rising 3.4% to reach 34.9 million. Consequently, the rising demand for minimally invasive techniques significantly drives the expansion of the occlusion devices market.
What Market Segments Are Evaluated Within The Occlusion Devices Market?
The occlusion devices market covered in this report is segmented –
1) By Product: Occlusion Removal Devices, Embolization Devices, Tubal Occlusion Devices, Support Devices
2) By Application: Neurology, Cardiology, Peripheral Vascular Diseases, Urology, Oncology, Gynecology
3) By End User: Hospitals Diagnostic Centers And Surgical Centers, Ambulatory Care Centers, Research Laboratories And Academic Institutes
Subsegments:
1) By Occlusion Removal Devices: Thrombectomy Devices, Catheter-Based Occlusion Removal Devices, Aspiration Systems, Mechanical Clot Retrieval Systems
2) By Embolization Devices: Coil Embolization Devices, Particle Embolization Devices, Balloon Embolization Devices, Gel Embolic Agents, Liquid Embolic Agents, Stent-Assisted Embolization Devices
3) By Tubal Occlusion Devices: Essure Devices, Hysteroscopic Sterilization Systems, Fallopian Tube Clips, Tubal Ligation Devices
4) By Support Devices: Occlusion Catheters, Guidewires For Occlusion, Supportive Sheaths, Stent-Grafts For Occlusion Support
What Industry Trends Are Redefining The Occlusion Devices Market?
Leading companies in the occlusion devices market are prioritizing the creation of innovative solutions, including next-generation devices, to enhance targeted embolization procedures. These next-generation devices represent an advanced iteration of existing technology, delivering superior performance, enhanced features, and novel capabilities. For example, in July 2025, Embolx, a US-based medical equipment manufacturer, introduced the Sniper G3 Balloon Occlusion Microcatheter, which significantly improves targeted embolization with greater efficiency, ease of use, and an extended shelf life. This third-generation device doubles its shelf life to 24 months, providing better inventory flexibility. Developed with direct feedback from interventional radiologists, it features improved trackability and a simplified preparation process that reduces setup time to under a minute. These enhancements demonstrate Embolx’s focus on physician-centered design, aimed at streamlining clinical workflows and optimizing procedural outcomes. The Sniper G3 is available in all standard lengths and is ready for global distribution, reinforcing its position as a leading tool in embolization therapy.
Who Are The Top Market Participants Influencing The Occlusion Devices Market?
Major companies operating in the occlusion devices market are Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Cook Group Incorporated, Merit Medical Systems Inc., Lepu Medical Technology Beijing Co. Ltd., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., Angiodynamics Inc., LeMaitre Vascular Inc., Elixir Medical Corporation, Vascular Concepts Ltd., Occlutech, W L Gore & Associates Inc., LifeTech Scientific Corporation, Cardiovascular Systems Inc., Venus Medtech, CeloNova Biosciences, Cordis Corporation, Pfizer Inc., Sirtex Medical Limited, Nordion Canada Inc., AtriCure Inc., Phenox GmbH, Balt Extrusion SAS
Read the full occlusion devices market report here:
https://www.thebusinessresearchcompany.com/report/occlusion-devices-global-market-report
Which Region Is Forecast To Lead The Occlusion Devices Market In Terms Of Market Size?
North America was the largest region in the occlusion devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the occlusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Occlusion Devices Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20584&type=smp
Browse Through More Reports Similar to the Global Occlusion Devices Market 2026, By The Business Research Company
Chronic Venous Occlusions Treatment Market Report 2026
Cardiovascular Surgery Devices And Equipment Market Report 2026
Peripheral Vascular Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model